Recombinant Human BMP-7 Biotinylated Protein Summary
Product Specifications
Ser293-His431
Analysis
Product Datasheets
BT354/CF (carrier free)
Discontinued Product
BT354
Formulation | Lyophilized from a 0.2 μm filtered solution in HCl with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in 4 mM HCl. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
Both Biotinylated Recombinant Human BMP-7 (Catalog # BT354) and unlabeled Recombinant Human BMP-7 (Catalog # 354-BP) induces alkaline phosphatase production in the ATDC5 mouse chondrogenic cell line. The ED50 for this effect is 100-600 ng/mL. The similarity in activity highlights that the biotinylated protein is fully functional.
Reconstitution Calculator
Background: BMP-7
Bone morphogenetic protein 7 (BMP-7), also known as osteogenic protein 1 (OP-1), is a widely expressed TGF-beta superfamily member with important functions during embryogenesis, in the adult, and in disease (1, 2). Human BMP-7 is synthesized with a 29 amino acid (aa) signal sequence, a 263 aa propeptide, and a 139 aa growth factor domain (3, 4). The growth factor domain of human BMP-7 shares 98% aa sequence identity with mouse and rat BMP-7. The BMP-7 propeptide is cleaved intracellularly but remains in association with the growth factor domain. BMP-7 is subsequently secreted as a tetramer that consists of two propeptides and two disulfide-linked growth factor domains (5, 6). Mature BMP-7 can also form disulfide-linked heterodimers with BMP-2 or BMP-4, complexes that show increased potency and range of activity compared to BMP-7 homodimers (7-9). The presence of the propeptides in the BMP-7 tetramer does not diminish the bioactivity of the growth factor domains (6). Secreted BMP-7 is immobilized in the extracellular matrix as a result of interactions between the propeptide and matrix Fibrillin (5). BMP-7 exerts its biological effects through the type 2 receptors Activin RIIA, Activin RIIB, and BMPR-II and the type 1 receptors Activin RIA, BMPR-IA, and BMPR-IB (2, 6). BMP-7 plays a role in a variety of organ systems. It promotes new bone formation and nephron development (10, 11), inhibits the branching of prostate epithelium (12), and antagonizes epithelial-mesenchymal transition (EMT) (13-15). In pathological conditions, BMP-7 inhibits tumor growth and metastasis (14), ameliorates fibrotic damage in nephritis (13), and promotes neuroregeneration following brain ischemia (16).
- Carreira, A.C. et al. (2015) J. Dent. Res. 93:335.
- Weiskirchen, R. and S.K. Meurer (2013) Front. Biosci. (Landmark Ed.) 18:1407.
- Ozkaynak, E. et al. (1990) EMBO J. 9:2085.
- Celeste, A.J. et al. (1990) Proc. Natl. Acad. Sci. USA 87:9843.
- Gregory, K.E. et al. (2005) J. Biol. Chem. 280:27970.
- Sengle, G. et al. (2008) J. Mol. Biol. 381:1025.
- Israel, D.I. et al. (1996) Growth Factors 13:291.
- Aono, A. et al. (1995) Biochem. Biophys. Res. Commun. 210:670.
- Nishimatsu, S. and G.H. Thomsen (1998) Mech. Dev. 74:75.
- Sampath, T.K. et al. (1992) J. Biol. Chem. 267:20352.
- Kazama, I. et al. (2008) J. Am. Soc. Nephrol. 19:2181.
- Grishina, I.B. et al. (2005) Dev. Biol. 288:334.
- Zeisberg, M. et al. (2003) Nat. Med. 9:964.
- Buijs, J.T. et al. (2007) Am. J. Pathol. 171:1047.
- Yu, M.-A. et al. (2009) J. Am. Soc. Nephrol. 20:567.
- Chou, J. et al. (2006) J. Neurol. Sci. 240:21.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human BMP-7 Biotinylated Protein
There are currently no reviews for this product. Be the first to review Recombinant Human BMP-7 Biotinylated Protein and earn rewards!
Have you used Recombinant Human BMP-7 Biotinylated Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image